At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Malnutriton Screening Tool (PYMS) (other)
- How long the study runs
- Study runs about 30 months (dates as stated)
- About the drug or intervention
- Malnutriton Screening Tool (PYMS) — other: In a pilot implementation study, PYMS will be used on children with IBD attending the outpatient and inpatient hospital clinics
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- 4 Years to 18 Years
- Who
- All
- Number of participants
- 2,000
- Started
- 2024-06-15
- Last checked
- 2026-08
Plain English Summary
What is this study?
- • Testing a new treatment for inflammatory bowel diseases (ibd)
- • Clinical study - 2,000 participants
- • Children with inflammatory bowel disease (IBD) including both Crohn's disease (CD) and ulcerative colitis (UC) can be at high risk of developing malnutrition due to the nature of their condition
Who can take part?
- • Ages 4 Years to 18 Years
- • Diagnosed with inflammatory bowel diseases (ibd)
Where?
- • Bristol - University Hospital Bristol and Weston
- • Edinburgh - Royal Hospital for Children and Young People
- • London - Great Ormond Street Hospital
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
Children with inflammatory bowel disease (IBD) including both Crohn's disease (CD) and ulcerative colitis (UC) can be at high risk of developing malnutrition due to the nature of their condition. It is also believed that some children with IBD, in need of nutritional care, are not identified quickly by their healthcare professionals. This may negatively affect their nutrition, disease progression and general well-being. Hence, it has been proposed that nutritional screening tools or scores (NSTs) should be used to promptly identify children needing further dietetic review and input. Although there are a few NSTs for generic use in sick children at hospital admission, NSTs or scores to use for children with IBD are currently missing. In this study, we would like to test the performance of an existing tool that is routinely used for all sick children at hospital admission (The Paediatric Yorkhill Malnutrition Score or PYMS)(5) and test whether PYMS can detect children with IBD who are at risk of malnutrition. If PYMS doesn't work well, we will develop a specific tool for children with IBD (The Paediatric IBD Nutrition Score or PIBD-NUTS).
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 4 Years - 18 Years
- Who can join: All genders
What the study is looking for
- ✓Pediatric patients with either Crohn's disease or ulcerative colitis between the ages of (4-18 years)
Who cannot take part
- ✗Pediatric patients with IBDU
See the full criteria
Where Is This Study? (3 UK sites)
University Hospital Bristol and Weston
Bristol, United Kingdom
Royal Hospital for Children and Young People
Edinburgh, United Kingdom
Great Ormond Street Hospital
London, United Kingdom
Main Email: Research.Governance@gosh.nhs.uk
Research.Governance@gosh.nhs.uk0207 905 2700